An introduction to telomeres and telomerase

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 24, Issue 3, 2003, Pages 295-301

  Bibby, Michael C ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Cancer marker; Cancer therapy; Immortalization; Telomerase; Telomeres

Indexed keywords

ANTINEOPLASTIC AGENT; TELOMERASE; TELOMERASE INHIBITOR;

ANTINEOPLASTIC ACTIVITY; CANCER; CELL AGING; CELL DIVISION; CELL IMMORTALIZATION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME STRUCTURE; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SOLID TUMOR; TELOMERE;

ANIMALS; CELL AGING; CELL DIVISION; DNA REPLICATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; TELOMERASE; TELOMERE;

EID: 0038115346     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:24:3:295     Document Type: Review

References (85)

1. Blackburn, E.H. (1991). Structure and function of telomeres. Nature 350, 569-573.
2. Zakian, V.A. (1989). Structure and function of telomeres. Ann. Rev. Gene. 23, 579-604.
3. Moyzis, R.K, Buckingham JM, Cram L.S., et al. (1988). A highly conserved repetitive DNA sequence (TTAG GG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA 85, 6622-6626.
4. Brown, W.R.A. (1989). Molecular cloning of human telomeres in yeast. Nature 338, 774-776.
5. Cross, S.H., Allshire, R.C., McKay, S.J., et al. (1989). Cloning of human telomeres by complementation in yeast. Nature 338, 771-774.
6. de Lange, T., Shiue, L., Myers, R.M., et al. (1990). Structure and variability of human chromosome ends. Mol. Cell Biol. 10, 518-527.
7. Hastie, N.D., Dempster, M., Dunlop, M.G., et al. (1990). Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866-868.
8. Henderson, E. (1995) in Telomeres. (Blackburn, E.H. and Greider, C. W., eds.) Cold Spring Harbour Laboratory Press, Cold Spring Harbor, NY, pp. 11-34,
9. Cooke, H.J. and Smith, B.A. (1986). Variability at the telomeres of the human X/Y pseudoautosomal region. Cold Spring Harb. Symp. Quant. Biol. 51, 213-219.
10. Prowse, K.R. and Greider, C.W. (1995). Developmental and tissue specific regulation of mouse telomerse and telomere length. Proc. Natl. Acad. Sci. USA 92, 4818-4822.
11. Allshire, R.C., Dempster, M., and Hastie, N.D. (1989). Human telomeres contain at least three types of G-rich repeats distributed non-randomly. Nucleic Acid Res. 17, 4611-4627
12. Lansdorp, P.M., Verwoerd, N.P., van de Rijke, F.M. et al. (1996). Heterogeneity in telomere length of human chromosomes. Human Mol. Genet. 5, 685-691.
13. Henderson, S., Allsopp, R., Spector, D., et al. (1996). In situ analysis of changes in telomere size during replicative ageing and cell transformation. J. Biol. Chem. 134, 1-12.
14. Buchkovich, K.J. and Greider, C.W. (1996). Telomerase regulation during entry into the cell cycle in normal human T cells. Mol. Biol. Cell 134, 1443-1454
15. Nakamura, T.M. and Cech, T.R. (1998). Reversing time: origin of telomerase. Cell 92, 587-590.
16. Weng, N.P., Levine, B.L., June, C.H., and Hodes, R.J. (1996). Regulated expression of telomerase activity in human T lymphocyte development and activation. J. Exp. Med. 183, 2471-2479.
17. Holt, S.E., Wright, W.E., and Shay, J.W. (1996). Regulation of telomerase activity in immortl cell lines. Mol. Cell Biol. 16, 2932-2939.
18. Shay, J.W. (1998). Telomerase in cancer: Diagnostic, prognostic and therapeutic implications. Cancer J. Sci. Am.4, S1, S26-S34.
19. Achi, M.V., Ravindranath, N., and Dym, M. (2000). Telomere length in male germ cells is inversely correlated with telomerase activity. Biol. Reprod. 63, 591-598.
20. Weinrich, S.I., Pruzan, R., Ma, L., et al. (1997). Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet. 17, 498-502.
21. Greider, C.W. and Blackburn, E.H. (1985). Identification of a specific telomere terminal transferase activity in tetrahymena extracts. Cell 43, 405-413.
22. Shippen-Lentz, D. and Blackburn, E.H. (1990). Functional evidence for an RNA template in telomerase. Science 269, 546-552.
23. Blasco, M.A., Funk, W., Villeponteau. B., and Greider, C.W. (1995). Functional characterization and developmental regulation of mouse telomerase RNA. Science 269, 1267-1270.
24. Feng, J., Funk, W.D., Wang, S.S., et al. (1995). The RNA component of human telomerase. Science 269, 1236-1241.
25. Nakamura, T.M., Morin, G.B., Chapman, K.B., et al. (1997). Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959.
26. Soder, A.I., Hoare, S.R., Muir, S., et al. (1997). Amplification, increased dosage and in situ expression of the telomerase RNA gene in human cancer. Oncogene 14, 1013-1021.
27. Soder, A.I., Hoare, S.F., Muire, S., et al. (1997). Mapping of the gene for the mouse telomerase RNA component, Terc, to chromosome 3 by fluorescence in situ hybridization and mouse chromosome painting. Genomics 41, 293-294.
28. Lingner, J., Hughes, T.R., Shevchenko, A., et al. (1997). Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276, 561-567.
29. Meyerson, M., Counter, C.M., Eaton, E.N., et al. (1997). hEST2, the putative human telomerase catalytic subunit gene, is upregulated in tumor cells and during immortalization. Cell 90, 785-795.
30. Killian, A., Bowtell, D.D.L., Abud, H.E., et al. (1997). Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Human Mol. Genet. 6, 2011-2019.
31. Harrington. L., McPhail, T., Mar, V., et al. (1997). A mammalian telomerase associated protein. Science 275, 973-977.
32. Zhao, J-.Q., Hoare, S.F., McFarlane, R., et al. (1998). Cloning and characterization of human and mouse telomerase RNA gene promoter sequences. Oncogene 16, 1345-1350.
33. Bachand, F. and Autexier, C. (2001). Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions. Mol. Cell. Biol. 21, 1888-1897.
34. Yi, X.M., White, D.M., Aisner, D.L., et al. (2000). An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2, 433-440.
35. Koyanagi, Y., Kobayashi, D., Yajima, T., et al. (2000). Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemic cells. Anticancer Res. 20, 773-778.
36. Krams, M., Claviez, A., Klapper, W., et al. (2000). Upregulated telomerase activity and high mRNA lew els of the catalytic telomerase subunit hTERT in Hodgkin and Reed Stemberg cells. Blood 96, 3142.
37. Ouellette, M.M., Aisner, D.L., Savre-Train, I., et al. (1999). Telomerase activity does not always imply telomere maintenance. Biochem. Biophys. Res. Comm, 254, 795-803.
38. Steensel, van B. and de Lange, T. (1997). Control of telomere length by the human telomeric protein TRF1. Nature 385, 740-743.
39. Smith, S., Giriat, I., Schmitt, A., and de Lange, T. (1998). Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 282, 1484-7.
40. Steensel, van B., Smogorzewska, A., and de Lange, T. (1998). TRF2 protects human telomeres from end to end fusions. Cell 92, 401-483.
41. Yokoyama, Y., Takahashi, Y., Shinohara, A., et al. (2000). The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. Bichem. Biophs. Res. Comm. 273, 316-321.
42. Harley, C.B. (1991). Telomere loss: mitotic clock or genetic time bomb? Mutation Res. 256, 271-282.
43. Avilion, A.A., Harrington, L.A., and Greider, C.W. (1992). Tetrahymena telomerase RNA levels increase during macronuclear development. Dev. Genet. 13, 80-86.
44. Price, C.M., Adams, A.K., and Vermeesch, J.R. (1994). Accumulation of telomerase RNA and telomere protein transcripts during telomere synthesis in Euplotes. J. Eukaryot. Microbio. 41, 267-275.
45. Villeponteau, B. (1996). The RNA components of human mouse telomerases. Cell Dev. Biol. 7, 15-21.
46. Bryan, T.M., Marusic, L., Bacchetti, S., et al. (1997). The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit, Human Mol. Genet. 6, 921-926.
47. Blasco, M., Lee, H.-W., Hande, M., et al (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34.
48. Lee, H.-W., Blasco, M.A., Gottlieb, G.J, et al. (1998). Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574.
49. Bodnar, A.G., Ouellette, M., Frolkis, M., et al. (1998). Extension of life-span by introduction of telomerase into no.mal cells. Science 279, 349-352.
50. Bacchetti, S. (1996). Telomere dynamics and telomerase activity in cell senescence and cancer. Cell Dev. Biol. 7, 31-39.
51. Shay, J.W. and Bacchetti, S. (1997). A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791.
52. Kim, N.W., Piatyszek, M.A., Prowse, K.R., et al. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2014.
53. Ballon, G., Trentin, L., de Rossi, A., and Semenzato, G. (2001). Telomerase activity and clinical progression in chronic lymphoproliferative disorders of B-cell lineage. Leuk. Lymphoma 41, 35.
54. Bialkowska-Hobrzanska, H., Bowles, L., Bukala, B., et al. (2000). Comparison of human telomerase reverse transcriptase messenger RNA and telomerase activity as urine markers for diagnosis of bladder carcinoma. Mol. Diag 5, 267-277.
55. Chang, J.T.C., Liao, C.T., Jung, S.M., et al. (2000). Telomerase activity is frequently found in metaplastic and malignant human nasopharyngeal tissues. Br. J. Cancer 82, 1946-1951.
56. Choi, L.M.R., Kim, N.W., Zuo, J.J., et al. (2000). Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma. Med. Pediatr. Oncol. 35, 647-650.
57. Hiyama, E., Saeki, T., Hiyama, K., et al. (2000). Telomerase activity as a marker of breast carcinoma in fine- needle aspirated samples. Cancer Cytopathol. 90, 235-238.
58. Poremba, C., Willenbring, H., Hero, B., et al. (1999). Telomerase activity distinguishes between neuroblastomas with good and poor prognosis. Ann. Oncol. 10, 715-721.
59. Uchida, N., Otsuka, T., Arima, F., et al. (1999). Correlation of telomerase activity with development and progression of adult T-cell leukemia. Leukemia Res. 23, 311-316.
60. Usselmann, B., Newbold, M., Morris, A., and Nwokolo, C.U. (2001). High tumour telomerase activity correlates with shortened patient survival and more advanced tumour stage in gastric but not in oesophageal adenocarcinoma. Gut 48, 176.
61. Yan, P., Coindre, J.M., Benhattar, J., et al. (1999). Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: Correlation with grade, histology, and proliferative activity. Cancer Res. 59, 3166-3170.
62. Yoo, J. and Robinson, R.A. (2000). Expression of telomerase activity and telomerase RNA in human soft tissue sarcomas. Arch. Pathol. Lab. Med. 124, 393-397.
63. Yoshida, R., Kiyozuka, Y., Ichiyoshi, H., et al. (1999). Change in telomerase activity during human colorectal carcinogenesis. Anticancer Res. 19, 2167-2172
64. Bamberger, C.M., Else, T., Bamberger, A.M., et al. (1999). Telomerase activity in benign and malignant adrenal tumors. Exp. Clin. Endocrinol. Diabet. 107, 272-275.
65. Arai, Y., Yajima, T., Yagihashi, A., et al. (2000). Limitations of urinary telomerase activity measurement in urothelial cancer. Clin. Chim. Acta. 296, 35-44.
66. Shroyer, K.R., Thompson, L.C., Enomoto, T., et al. (1998). Telomerase expression in normal epthelium, reactive atypia, squamous dysplasia and squamous cell carcinoma of the uterine cervix. Am. J. Clin. Patrol. 109, 153-162.
67. Yokoyama, Y., Takahashi, Y., Shinohara, A., et al. (1998). Telomerase activity in the female reproductive tract and neoplasms. Gynecol. Oncol. 68, 145-149.
68. Mayfield, M.P., Shah, T., Flannigan, G.M., et al. (1998). Telomerase activity in malignant and benign bladder conditions. Int. J. Mol. Med. 1, 835-840.
69. Kim, N.W. (1997). Clinical implications of telomerase in cancer. Eur. J. Cancer 33, 781-786.
70. Carey, L.A., Kim, N.W., Goodman, S., et al. (1999). Telomerase activity and prognosis in primary breast cancers. J. Clin. Oncol. 17, 3075-3081.
71. Dunham, M.A., Neumann, A.A., Fasching, C.L., et al. (2000). Telomere maintenance by recombination in human cells. Nat. Genet. 26, 447-450.
72. Keith, W.N., Sarvesvaran, J., and Downey, M. (2002). Analysis of Telomerase RNA Gene Expression by in situ hybridization. In: Methods in Molecular Biology vol. 191, Telomeres and Telomerase (Double, J.A. and Thompson, M.J., eds.) Humana Press, Totowa, NJ, pp. 65.
73. Wei, R. and Younes, M., (2002). Immunohistochemical detection of telomerase reverse transcriptase in colorectal adenocarcinoma and benign colonic mucosa. Human Pathol. 33, 693-696.
74. Masutomi, K., Kaneko, S., Yasukawa, M., et al. (2002). Identification of serum anti-human telomerase reverse transcriptase (hTERT) auto-antibodies during progrssion to hepatocellular carcinoma. Oncogene 21, 5946-5950.
75. Kelland, L.R.. (2001) Telomerase:Biology and phase I trials. THE LANCET Oncology 2, 95-101.
76. Hahn, W.C., Stewart, S.A., Brooks, M.W., et al. (1999) Inhibition of telomerase limits the growth of human cancer cells. Nat. Med. 5, 1164-1170.
77. Zhang, L., Mar, V., Zhou, W., et al. (1999) Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 13, 2388-2399.
78. Neidle, S. and Parkinson, G. (2002). Telomere maintenance as a target for anticancer drug discovery. Nat. Rev. Drug Disc. 1, 383-393.
79. Kondo, S., Kondo, Y., Li, G., et al. (1998) Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene 16, 3323-3330.
80. Yokoyama, Y., Takahashi, Y., Shinohara, A., et al. (1998). Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells. Cancer Res. 58, 5406-5410.
81. Hamilton, S.E., Simmons, C.G., Kathiriya, I.S., et al. (1999). Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem. Biol. 6, 343-351.
82. Zahler, A.M., Williamson, J.R., Cech, T.R., et al. (1991). Inhibition of telomerase by G-quartet DNA structures. Nature 350, 718-720.
83. Mergny, J.-L., Mailliet, P., Lavelle, F., et al. (1999). The development of telomerase inhibitors: the G-quartet approach. Anticancer Drug Des. 14, 327-339.
84. Gowan, S.M., Heald, R., Stevens, M.F.G., et al. (2001) Potent Inhibition of Telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. Mol. Pharmacol, 60, 981-988.
85. Blackburn, E.H. (2000) Telomere states and cell fates. Nature 408, 53-56.